Abstracts Archive - Page 2250 of 2425 - ACR Meeting Abstracts

Abstract Number: 2600 • 2012 ACR/ARHP Annual Meeting
Assessment of Quality of Care for Incident Lupus Nephritis in the U.S. Medicaid Population
Jinoos Yazdany¹, Candace H. Feldman², Jun Liu³, Michael M. Ward⁴, Michael A. Fischer⁵ and Karen H. Costenbader⁶, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, ⁴Bldg 10 CRC Rm 4-1339, NIAMS/NIH, Bethesda, MD, ⁵Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, ⁶Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: The contribution of uneven health care quality to racial/ethnic and socioeconomic disparities in lupus nephritis outcomes is unknown. We aimed to assess performance on…
Abstract Number: 2601 • 2012 ACR/ARHP Annual Meeting
Improving Delivery of Care for JIA Across a Multi-Center Network Using a Shared Data Registry and Quality Improvement Science: The Pediatric Rheumatology Care and Outcomes Improvement Network
Catherine A. Bingham¹, Lynn M. Darbie², Keith Marsolo³, Jennifer E. Weiss⁴, Stacy P. Ardoin⁵, Ronald Laxer⁶, D. J. Lovell⁷, Murray H. Passo⁸, Sheetal Vora⁹, Beth S. Gottlieb¹⁰, Timothy Beukelman¹¹, Nancy Griffin², Jason A. Stock¹², Michael L. Miller¹³, Karen Onel¹⁴, Tova Ronis¹⁵, Peter Margolis¹⁶ and Esi M. Morgan DeWitt¹⁷, ¹Pediatric Rheumatology, Penn State Hershey Children's Hospital, Hershey, PA, ²James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Division of Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH, ⁴Pediatric Rheumatology, Hackensack University Medical Center, Hackensack, NJ, ⁵Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, ⁶Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁷Cincinnati Children's Hospital, Cincinnati, OH, ⁸Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, ⁹Pediatric Rheumatology, Medical College of Wisconsin, Milwaukee, WI, ¹⁰Pediatric Rheumatology, Cohen Children's Medical Center of New York, New Hyde Park, NY, ¹¹Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ¹²Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹³Rheumatology, Childrens Memorial Hospital, Chicago, IL, ¹⁴Pediatric Rheumatology, University of Chicago, Chicago, IL, ¹⁵Pediatric Rheumatology, Stanford University Hospital, Palo Alto, CA, ¹⁶Clinical Effectiveness, Cincinnati Children's Hospital, Cincinnati, OH, ¹⁷Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a quality improvement (QI) multi-center “learning network” that performs QI and research while tracking…
Abstract Number: 2602 • 2012 ACR/ARHP Annual Meeting
The Rheumatology Informatics System for Effectiveness (RISE): Enabling Data Access Across Disparate Sites for Quality Improvement and Research
Peter J. Embi¹, Itara Barnes², Rachel Myslinski³, David Ervin⁴, William Stevens⁴, Tara Borlawsky¹ and Philip R.O. Payne¹, ¹Biomedical Informatics & Internal Medicine, The Ohio State University, Columbus, OH, ²Quality, Registries, and Health Informatics, American College of Rheumatology, Atlanta, GA, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, ⁴The Ohio State University, Columbus, OH
Background/Purpose: Rheumatology quality improvement efforts and clinical research are often challenged by the need to access and integrate data across diverse patient populations and disparate information…
Abstract Number: 2603 • 2012 ACR/ARHP Annual Meeting
Moving Into the Electronic Age: Validation of Rheumatology Self-Assessment Questionnaires On Tablet Computers
Jessica M. Sage¹, Arshia Ali², Jennifer Farrell³, Jennifer L. Huggins⁴, Kara Covert³, Diane Eskra⁵, Rina Mina³, Shweta Srivastava³, Janalee Taylor⁶, Tracy V. Ting⁴, Esi M. Morgan DeWitt³ and Hermine Brunner⁴, ¹Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Internal Medicine, University of Cincinnati, Cincinnati, OH, ³Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁵James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁶William S. Rowe Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose: The medical field is increasingly relying on electronic health records (EHR). Many children’s hospitals are converting from paper-pencil questionnaires to electronic versions. The purpose…
Abstract Number: 2604 • 2012 ACR/ARHP Annual Meeting
Ask a Doc – Rheumatologic Care Delivered Just in Time
Eric D. Newman¹, Chelsea Cedeno², Thomas M. Harrington³, Thomas P. Olenginski³, Alfred E. Denio³, Androniki Bili⁴, Brian DelVecchio⁵, Carolyn Houk⁶ and Paul F. Simonelli⁷, ¹Department of Rheumatology, Geisinger Health System, Danville, PA, ²Division of Medicine, Geisinger Medical Center, Geisinger Health System, Danville, PA, ³Dept of Rheumatology, Geisinger Health System, Danville, PA, ⁴Rheumatology, Geisinger Medical Center, Danville, PA, ⁵Rheumatology, Geisinger Health System, Wilkes-Barre, PA, ⁶Family Practice - Frackville, Geisinger Health System, Frackville, PA, ⁷Thoracic Medicine, Geisinger Medical Center, Danville, PA
Background/Purpose: Specialty care is traditionally delivered as face to face consults. These encounters range from consult not needed to consult needed quickly. Our care systems…
Abstract Number: 2605 • 2012 ACR/ARHP Annual Meeting
Exploration of Possible Preliminary Descriptions of Remission Based On RAPID3, without Laboratory Tests or Formal Joints Counts but with Careful Joint Examinations, in the Etude Et Suivi Des Polyarthrites Indifférenciées Récentes (ESPOIR) Cohort of Early Rheumatoid Arthritis Patients
Isabel Castrejón¹, Maxime Dougados², Bernard Combe³, Bruno Fautrel⁴ and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France, ³Rheumatology, Hopital Lapeyronie, Montpellier, France, ⁴Rheumatology / GRC08-EEMOIS, APHP-Pitie Salpetriere Hospital / UPMC, Paris, France
Background/Purpose: Criteria for remission in rheumatoid arthritis (RA) have been developed according to DAS28 (disease activity score), CDAI (clinical disease activity index), and two recent…
Abstract Number: 2566 • 2012 ACR/ARHP Annual Meeting
Aβ-Related Angiitis: Comparison with Patients with Amyloid Cerebral Angiopathy without Inflammation
Carlo Salvarani¹, Caterina Giannini², Robert D. Brown Jr.², Teresa J. H. Christianson² and Gene G. Hunder³, ¹Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, ²Mayo Clinic, Rochester, MN, ³Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Coexistence of sporadic cerebral amyloid angiopathy (CAA) and primary central nervous system vasculitis (PCNSV) has been reported, particularly in patients with granulomatous vasculitis. This…
Abstract Number: 2567 • 2012 ACR/ARHP Annual Meeting
Predictive Value of Selected Markers of Inflammation and Platelet Activation for Complete Remission in ANCA – Associated Vasculitis
Gunnar Tomasson¹, Paul A. Monach², Kahraman Tanriverdi³, Ulrich Specks⁴, John H. Stone⁵, Linna Ding⁶, Fernando Fervenza⁴, Gary S. Hoffman⁷, Cees G.M. Kallenberg⁸, Carol A. Langford⁹, Deborah J. Phippard¹⁰, Philip Seo¹¹, Robert F. Spiera¹², E. William St. Clair¹³, Nadia Tchao¹⁰, Jane E. Freedman³ and Peter A. Merkel¹⁴, ¹Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland, ²Rheumatology, Boston University, Boston, MA, ³Department of Cardiology, University of Massachusetts, Wochester, MA, ⁴Mayo Clinic, Rochester, MN, ⁵Rheumatology, Massachusetts General Hospital, Boston, MA, ⁶NIAID, Bethesda, MD, ⁷Rheumatic & Immunologic Dis, Cleveland Clinic, Cleveland, OH, ⁸Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, ⁹Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, ¹⁰Immune Tolerance Network, Bethesda, MD, ¹¹Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, ¹²Rheumatology, Hospital for Special Surgery, New York, NY, ¹³Medicine, Duke University Medical Center, Durham, NC, ¹⁴University of Pennsylvania, Philadelphia, PA
Background/Purpose: Most subjects with ANCA –associated vasculitis (AAV) respond to treatment for remission induction, but predictors for complete disease remission are lacking. We have previously…
Abstract Number: 2568 • 2012 ACR/ARHP Annual Meeting
The Risk of Pulmonary Embolism and Deep Vein Thrombosis in Giant Cell Arteritis: A Population-Based Cohort Study
J. Antonio Avina-Zubieta¹, Diane Lacaille², Eric C. Sayre³, Jacek A. Kopec³ and Hyon Choi⁴, ¹Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, ²Rheumatology, Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Arthritis Research Centre of Canada/University of British Columbia, Boston, MA
Background/Purpose: A recent hospital-based study has suggested an 8 fold increased risk of pulmonary embolism (PE) in individuals with polymyalgia rheumatica in the year following…
Abstract Number: 2569 • 2012 ACR/ARHP Annual Meeting
Hydroxychloroquine Reduces Thrombosis in Systemic Lupus Erythematosus, Particularly in Antiphospholipid Positive Patients
Genevieve Law¹, Laurence S. Magder², Hong Fang³ and Michelle Petri³, ¹Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada, ²Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Past studies, mostly cross-sectional, have found a reduction in thrombosis in systemic lupus erythematosus (SLE) patients taking hydroxychloroquine (HCQ). We examined the relationship between…
Abstract Number: 2570 • 2012 ACR/ARHP Annual Meeting
Lymphoma Risk in Systemic Lupus: Effects of Disease Activity Versus Treatment
Sasha Bernatsky¹, Ann E. Clarke², Karen H. Costenbader³, Murray B. Urowitz⁴, Dafna D. Gladman⁵, Paul R. Fortin⁶, Michelle Petri⁷, Susan Manzi⁸, D.A. Isenberg⁹, Anisur Rahman¹⁰, Daniel Wallace¹¹, Caroline Gordon¹², Christine Peschken¹³, Mary Anne Dooley¹⁴, E.M. Ginzler¹⁵, Cynthia Aranow¹⁶, Steven M. Edworthy¹⁷, Ola Nived¹⁸, Søren Jacobsen¹⁹, Guillermo Ruiz-Irastorza²⁰, Edward H. Yelin²¹, Susan G. Barr²², Irene Blanco²³, Candace H. Feldman²⁴ and R. Ramsey-Goldman²⁵, ¹Clinical Epidemiology, Systemic Lupus International Collaborating Clinics, Montreal, QC, Canada, ²Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ³Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁴Division of Rheumatology, Toronto Western Hospital and University of Toronto,, Toronto, ON, Canada, ⁵Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁶University of Laval, Quebec, QC, ⁷Johns Hopkins University School of Medicine, Baltimore, MD, ⁸Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁹Centre for Rheumatology Research, University College London, London, United Kingdom, ¹⁰Centre for Rheumatology Research,Rayne Institute, 4th Floor, University College London, London, United Kingdom, ¹¹Cedars-Sinai/UCLA, Los Angeles, CA, ¹²School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ¹³Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ¹⁴University of North Carolina at Chapel Hill, Chapel Hill, NC, ¹⁵Rheumatology, SUNY-Downstate Medical Center, Brooklyn, NY, ¹⁶Feinstein Institute for Medical Research, Manhasset, NY, ¹⁷The University of Calgary, Calgary, AB, Canada, ¹⁸Department of Clinical Science, Lund University, Rheumatology, Lund, Sweden, ¹⁹Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, ²⁰Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain, ²¹Medicine, UC San Francisco, San Francisco, CA, ²²University of Calgary, University of Calgary, Calgary, AB, Canada, ²³Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ²⁴Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²⁵Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: In systemic lupus (SLE), concern exists about immunosuppressive drugs and lymphoma risk, Yet, the relative influence of disease activity vs treatment, is unknown. Our objective…
Abstract Number: 2571 • 2012 ACR/ARHP Annual Meeting
Lack of Control of Hypertension in Systemic Lupus Erythematosus
Hong Fang¹, Raheel Ahmad², Laurence S. Magder³ and Michelle Petri¹, ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD
Background/Purpose: Hypertension is an independent risk factor for both actual cardiovascular events and also subclinical atherosclerosis (coronary calcium, carotid IMT) in SLE. We examined the…
Abstract Number: 2572 • 2012 ACR/ARHP Annual Meeting
Molecular Signatures in SLE: Flare Vs. Infection
Meggan Mackay¹, Michaela Oswald², Jorge Sanchez-Guerrero³, Juan J. Lichuaco⁴, Cynthia Aranow⁵, Sean Kotkin⁶, Peter K. Gregersen⁷ and Betty Diamond⁸, ¹Autoimmune & Musculoskeletal Disease, Feinstein Institute for Medical Research, Manhasset, NY, ²Laboratory of Genomics and Human Genetics, The Feinstein Institute for Medical Research, Manhasset, NY, ³UHN Toronto Western Hospital, Toronto, ON, Canada, ⁴Medicine, St. Luke's Medical Center, Quezon City, Philippines, ⁵Feinstein Institute for Medical Research, Manhasset, NY, ⁶Autoimmune & Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, NY, ⁷Genomics and Human Genetics, The Feinstein Institute for Medical Research, Manhasset, NY, ⁸Autoimmune & Musculoskeletal, Feinstein Institute Med Rsch, Manhasset, NY
Background/Purpose: Inability to distinguish between infection and the inflammatory response related to SLE disease activity using clinical judgment often compromises timely and effective treatment. Gene…
Abstract Number: 2573 • 2012 ACR/ARHP Annual Meeting
Arthoplasty Rates Increased Among US Patients with Systemic Lupus Erythematosus: 1991-2005
Christina Mertelsmann-Voss¹, Ting Jung Pan², Huong Do², Mark P. Figgie³ and Lisa A. Mandl⁴, ¹Pediatric Rheumatology, Hospital for Special Surgery, Cornell University, New York, NY, ²Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, ³Orthopedics, Hospital for Special Surgery, New York, NY, ⁴Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: There is little data regarding patterns of arthroplasty use in patients with Systemic Lupus Erythematosus (SLE). This study evaluates trends in total joint replacement…
Abstract Number: 2574 • 2012 ACR/ARHP Annual Meeting
Smoking, Autoantibodies and Vascular Events in Systemic Lupus Erythematosus
Johanna Gustafsson¹, Iva Gunnarsson¹, Susanne Pettersson¹, Agneta Zickert¹, Anna Vikerfors², Erik Hellbacher², Sonia Möller¹, Kerstin Elvin³, Henrik Källberg⁴, Julia F. Simard⁵ and Elisabet Svenungsson¹, ¹Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, ²Department of Medicine, Karolinska Institutet, Stockholm, Sweden, ³Department of Clinical Immunology and Transfusion Medicine,, Karolinska Institutet, Stockholm, Sweden, ⁴Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁵Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Smoking is a risk factor for several autoimmune diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Smoking is also a major risk…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].